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Background: Infratrochlear neuralgia is a recently described painful cranial 
neuropathy that causes pain in the internal angle of the orbit and the medial upper 
eyelid, the upper bridge of the nose and/or the lacrimal caruncle. We aim to present 
seven new cases of infratrochlear neuralgia treated with anaesthetic nerve blocks. 
Methods: Over an 18-month period, we prospective identified seven cases of 
infratrochlear neuralgia among the patients attending the Headache Unit in a 
tertiary hospital. Anaesthetic blocks were performed by injecting 0.5 cc of 
bupivacaine 0.5% at the emergence of the nerve above the internal canthus. 
Results: All patients were women, and the mean age was 49.1 years (standard 
deviation, 17.9). The pain appeared at the internal angle of the orbit and/or the 
medial upper eyelid in six cases, and the whole territory of the infratrochlear nerve 
in one case. Six patients had continuous pain and one had episodes lasting 8-24 
hours. All patients showed sensory disturbances within the painful area and 
tenderness upon palpation of the infratrochlear nerve. Nerve blocks resulted in 
complete and long-lasting relief in four patients and short-lasting relief in the other 
three patients.  
Conclusions: Infratrochlear neuralgia should be considered among the neuralgic 
causes of orbital and periorbital pain. Anaesthetic blocks may assist clinicians in the 
diagnosis and may also be an effective therapy.  
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Infratrochlear neuralgia is a painful cranial neuropathy recently described as a 
cause of orbital or periorbital pain (1). It is characterized by pain in the territory 
supplied by the infratrochlear nerve (i.e. the internal angle of the orbit and the 
medial upper eyelid, the upper bridge of the nose and/or the lacrimal caruncle) as 
well as tenderness upon palpation of the emergence of the infratrochlear nerve 
above the internal canthus.  
 
So far, eight cases of infratrochlear neuralgia have been reported (1,2). All the 
reported patients had brief paroxysms of pain in one of the three different locations 
mentioned above. In addition, all of them had local allodynia between attacks. 
Triggers such as light touch were identified by a minority of patients. Most patients 
have been treated with oral drugs (gabapentin) with satisfactory response. 
Nonetheless, anaesthetic blocks proved to be a safe and effective treatment in two 
of the reported patients (1,2).  
 
We aim to present seven new cases of infratrochlear neuralgia treated with 
anaesthetic blocks in the Headache Unit of a tertiary hospital and thus contribute to 




Between May 2015 and October 2016, seven cases of infratrochlear neuralgia were 
prospectively identified among the patients attending the Headache Unit in a 
tertiary referral hospital. We registered demographic data and a detailed history, 
including their complete medical record and the coexistence of other types of 
headache. Pain characteristics were carefully evaluated, including the exact location 
of the pain, the intensity and character of the pain, the temporal pattern, any other 
associated symptoms, and whether or not there was a precipitating event.  
 
A thorough physical and neurological examination was performed, including 
inspection and exhaustive sensory examination of the orbital and periorbital areas 
as well as palpation of the trochlear area and the emergence of the supraorbital, 
supratrochlear, infratrochlear and infraorbital nerves. Eye disorders were excluded 
by a thorough ophthalmological examination, including funduscopy, optometry, slit 
lamp examination, intraocular pressure measurements, testing of visual fields, and 
the Schirmer test. Magnetic resonance imaging (MRI) of the brain and the orbit and 
routine blood workup including erythrocyte sedimentation rate, C-reactive protein, 
thyroid tests and immunological screening were obtained in all cases to exclude any 
other underlying disease.  
 
Superficial anaesthetic blockades of the infratrochlear nerve were performed in all 
cases. We injected 0.5 cc of bupivacaine 0.5% with a 30-gauge needle through the 
internal angle of the orbit just above the internal canthus, i.e. the emergence point 
of the infratrochlear nerve (Figure 1). After 5 to 10 minutes, we assessed the 
topographic distribution of the anaesthetized area (Figure 2). The effectiveness of 
the anaesthetic block was assessed immediately after the procedure and during 
follow-up.  
 




The main demographic and clinical characteristics of the patients included in this 
series are shown in Table 1. All six patients were women. Mean age was 49.1 years 
(standard deviation [SD] 17.9; median 42; range 35-85), and mean age at onset was 
49 years (SD 18; median 42; range 34-85). The time since the onset of the symptoms 
ranged from 24 hours to 1 year. Six patients had previous migraine and one had 
ipsilateral epicrania fugax. Yet, the appearance of the new pain was not temporally 
connected to the prior headaches. One patient started to have the pain immediately 
after nasal trauma, while two patients related the pain to an episode of trochleitis. 
Trochleitis was satisfactorily treated by steroid injection near the trochlea in both 
patients, but they were left with pain confined to the territory of the infratrochlear 
nerve. Four patients did not have any precipitating event. 
 
Four patients felt pain on the left side, and three had pain on the right side. 
Specifically, four patients localized the pain at the internal angle of the orbit and the 
medial upper eyelid, one patient had pain restricted to the medial upper eyelid, 
another one complained of pain in the internal angle of the orbit and the last one 
had pain in the whole territory of the infratrochlear nerve including the internal 
angle of the orbit, the upper eyelid, the lateral aspect of the nasal bridge and the 
lacrimal caruncle. Pain location did not change during follow-up. Six patients had a 
continuous pain, while the remaining patient had a strictly episodic pattern with 1-
2 attacks per week lasting 8-24 hours.  
 
Basal pain was graded as mild (2-3 on a 10-point scale, n=2), moderate (4-6 on a 10-
point scale, n=3) or severe (7-8 on a 10-point scale, n=2), with either pressing (n=4) 
or stabbing (n=3) quality. Superimposed on the background pain, three patients 
experienced exacerbations of severe or very severe pain (8-10 on a 10-point scale), 
with pressing (n=1), stabbing (n=1) or electric (n=1) quality. Two of these patients 
had ultrashort paroxysms lasting up to a few seconds and triggered by touch, while 
the other patient had transient increases of her background pain lasting 1-2 hours 
coinciding with psychological stress or horizontal eye movements. None showed 
autonomic symptoms or other accompaniments. In all cases, simple analgesics or 
non-steroidal anti-inflammatory drugs had been tried, without success.  
 
All patients had hypersensitivity when the emergence of the infratrochlear nerve 
was palpated at the superointernal angle of the orbit, just above the internal 
canthus. Sensory examination of the painful area demonstrated sensory dysfunction 
in all cases, with hyperalgesia and allodynia (n=3), isolated allodynia (n=1), isolated 
hyperalgesia (n=1), hyperaesthesia (n=1) or hypoaesthesia (n=1). None of the 
patients had evidence of trochlear inflammation at the time of assessment. Complete 
blood workup as well as contrast-enhanced MRI of the brain and orbits were normal 
in all patients.  
 
All patients underwent an anaesthetic blockade of the infratrochlear nerve, as 
described above (Figure 1). Five to ten minutes after the procedure, an anesthetic 
area that matched the complete territory of the nerve was verified (Figure 2). No 
complications were derived from the intervention. Pain relief was immediately 
obtained in all cases, thus confirming the diagnosis of infratrochlear neuralgia. 
Three patients had an early recurrence after 48 hours, whereas four patients had a 
long-lasting effect. Two of the patients with early recurrence had partial 
improvement (>50% decrease in the frequency and intensity of exacerbations), and 
none of them was prescribed oral drugs. As for the patients with long-lasting effect, 
one required a second nerve block one month after the first procedure, but all of 




The infratrochlear nerve is one of the terminal branches of the nasociliary nerve, 
which stems from the first division (ophthalmic division) of the trigeminal nerve.  
Within the orbit, the nerve runs along the inferior edge of the superior oblique 
muscle and exits the orbit in an inferior position relative to the throclea. It has three 
major branches that provide innervation to three distinct areas: the medial aspect 
of the upper eyelid and the internal angle of the orbit, the lateral aspect of the bridge 
of the nose and the lacrimal sac and caruncle (3).  
 
Infratrochlear neuralgia was first described in 2015 and, so far, only eight cases have 
been communicated (1,2). We provide new evidence for the existence of this 
condition by reporting seven additional cases. The main features of all patients 
described to date are shown in Table 2. Former and current reports indicate that 
infratrochlear neuralgia is a female-predominant disorder, and that it may occur at 
a wide range of ages. Most cases have been idiopathic, but three patients in the 
current series had a precipitating event. Two of these patients started to have 
features of infratrochlear neuralgia after a trochleitis was resolved, and one case 
occurred after nasal trauma. In the cases preceded by trochleitis, swelling of the 
trochlea could have damaged the infratrochlear nerve due to its anatomical location 
(4,5). External trauma could be, as well, a precipitating event, as has been shown in 
supraorbital neuralgia (6,7). Some of the idiopathic cases might be also related to 
mechanical factors such as subtle trauma during eye movements or compression of 
the infratrochlear nerve from other structures along its trajectory within the orbit.  
 
Most patients with infratrochlear neuralgia localize their pain in the internal angle 
of the orbit and/or the medial upper eyelid, but the upper nasal bridge and the 
lacrimal caruncle can also be involved. Unlike the previously reported cases, which 
presented as paroxysmal pain, most of our patients had a continuous pain. Such 
heterogeneity in the temporal pattern is similar to that described in other 
pericranial neuralgias that may manifest as a paroxysmal or continuous pain (8,9). 
In infratrochlear neuralgia, the pain may acquire a pressing, stabbing or electric 
quality, and may be of mild, moderate or severe intensity, with occasional 
exacerbations. In a minority of patients, light touch may trigger or aggravate the 
pain. On physical examination, patients with infratrochlear neuralgia typically 
exhibit tenderness upon palpation of the emergence of the nerve at the internal 
angle of the orbit, just above the internal canthus. In addition, all the reported cases 
had symptoms and signs of sensory dysfunction within the affected area, such as 
allodynia, hyperalgesia and hypoaesthesia.   
 
Infratrochlear neuralgia may be mistaken for trochlear pain -either trochleitis or 
primary trochlear headache- given that both disorders cause pain and tenderness 
in the internal angle of the orbit (4,10,11). Nonetheless, trochlear pain has a wider 
distribution, exceeding the territory supplied by the infratrochlear nerve. Moreover, 
trochlear pain is typically continuous and is exacerbated by vertical eye movements. 
As stated above, trochlear pain and infratrochlear neuralgia may be somehow 
related due to the anatomical proximity of the trochlear apparatus and the 
infratrochlear nerve (5). However, the therapeutic approach should be different. 
While trochlear pain responds to injections of corticosteroids near the trochlea (11), 
infratrochlear neuralgia has been treated with antiepileptics or superficial 
anaesthetic blocks with excellent response (1,2) Although trochlear injection of 
corticosteroids has not been tried in infratrochlear neuralgia, we have not 
registered alleviation of the pain from infratrochlear neuralgia upon treatment of 
trochleitis. 
 
Besides trochlear pain, other disorders can cause pain in the orbital and periorbital 
region and should be differentiated from infratrochlear neuralgia. That is the case 
of first-division trigeminal neuralgia (12-14), which affects a wider area and 
appears as electric shock-like pains commonly provoked by innocuous stimuli. 
Other terminal branch neuropathies such as supraorbital neuralgia (6,7), lacrimal 
neuralgia (15,16) and infraorbital neuralgia (17,18) may be distinguished by the 
anatomical distribution of the pain. Trigeminal autonomic cephalalgias may also 
cause pain in the orbital and periorbital region, but they are typically associated 
with autonomic features (12,19-21). Migraine may also affect the orbital and 
periorbital area, but the pain in migraine is normally more diffuse and has typical 
migrainous accompaniments (12,22).  Primary stabbing headache commonly affects 
the periocular area, but the pain lasts just a few seconds and its location shows great 
variability even within the same individual (12,23). Idiopathic ophthalmodynia and 
idiopathic rhinalgia also produce pain in this region (24,25), but the distribution of 
the pain affects the eye globe or the nose without matching the distribution of any 
particular nerve. Several disorders of the eye and the orbit (26,27) must be also 
considered, but they can be appropriately excluded by ophthalmological and 
radiological exams.  
 
In conclusion, infratrochlear neuralgia should be considered amongst the causes of 
orbital and periorbital pain and has distinct clinical and exploratory features. 










 Seven more cases of infratrochlear neuralgia have been reported, expanding 
the spectrum of the disease. 
 All patients were treated with anaesthetic nerve blocks with short or long-
lasting response, and no complications were derived from the procedure.  
 Infratrochlear neuralgia should be considered in the differential diagnosis of 
orbital and periorbital pain, and it may be treated safely and effectively with 
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Figure 1. Infratrochlear nerve block: The needle is inserted through the internal 
angle of the orbit, just above the internal canthus. 
 
Figure 2. Infratrochlear nerve block: Topographic distribution of the anaesthetized 
area matching the whole skin territory of the lacrimal nerve. 
 
 
